Tag Archives: Precision Medicine

Watch our CEO Robert Thong talk about how we are advancing precision medicine for metabolic-syndrome-related conditions at the LSX Investival Showcase in London.

Read more

MultiOmic Health, a leading AI-enabled drug discovery company, announces the identification of novel patient endotypes and the development of proprietary biomarkers for stratifying diabetic kidney disease (DKD) patients.

Read more

We’re thrilled to announce our participation at #BioEquityEurope 2024!
Robert Thong, our CEO at MultiOmic Health, will be presenting on our innovative approach to tackle cardiorenal complications. Join us for insights into how we aim to transform the landscape of metabolic syndrome through precision medicine.

Read more

We are excited to announce our feature in the most recent edition of Nature Portfolio’s Biopharma Dealmakers discussing the advances in AI-driven drug development.

Read more

4/4